Author:
You Tingting,Tang Hui,Wu Wenjing,Gao Jingxi,Li Xuechun,Li Ningning,Xu Xiuxiu,Xing Jiazhang,Ge Hui,Xiao Yi,Guo Junchao,Wu Bin,Li Xiaoyi,Zhou Liangrui,Zhao Lin,Bai Chunmei,Han Qin,Sun Zhao,Zhao Robert Chunhua
Subject
Cell Biology,Neurology (clinical),Geriatrics and Gerontology,Pathology and Forensic Medicine
Reference49 articles.
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 71:209-249.
2. Zhang P, Gu Y, Fang H, Cao Y, Wang J, Liu H, et al. (2022). Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer. J Immunother Cancer, 10.
3. (2010). Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis. Ont Health Technol Assess Ser, 10:1-48.
4. Morad G, Helmink BA, Sharma P, Wargo JA (2021). Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell, 184:5309-5337.
5. Chen X, Song E (2019). Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov, 18:99-115.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献